NCT05175612

Differentiation of Upper and Lower Respiratory Tract Infections Using Automated Lung Sound Analysis With LungPass Device

• Status: Suspended
• Phase: —
• Study type: Observational
• Enrollment: 400 (estimated)
• Sponsor: Healthy Networks · Industry
• Sex: All
• Age: 3 Years
• Healthy volunteers: Not accepted

Summary

This observational study evaluates whether lung sound analysis with LungPass device can be used to differentiate upper and lower respiratory tract infections (URTI and LRTI)

Detailed description

This is a prospective observational study comprised patients presenting with acute respiratory tract infection symptoms in primary care settings. Patients will undergo routine clinical examination including lung auscultation with conventional stethoscope and LungPass device. Moreover, symptoms and anamnesis data, result of diagnostic questionnaire from the LungPass App, complete blood count, C-reactive protein, procalcitonin (PCT) level, SARS-CoV-2 PCR test and X-ray chest examination or CT chest (in case of preliminary clinical suspicion of LRTI). Patients will be followed up within 5-7 days and at the end of the disease in person or by phone for clinical course of the disease assessment to confirm the final diagnosis (URTI or LRTI). Final diagnosis will be considered as Gold standard for accuracy assessment.

Conditions

• Acute Respiratory Tract Infection

Interventions

Type	Name	Description
DEVICE	Lung auscultation with LungPass device (electronic auscultation)	Lung auscultation with electronic stethoscope

Timeline

• Start date: 2021-11-16
• Primary completion: 2022-11-30
• Completion: 2022-11-30
• First posted: 2022-01-04
• Last updated: 2022-06-07

Locations

1 site across 1 country: Belarus